Track topics on Twitter Track topics that are important to you
Radium-223 dichloride shows good long-term safety for treating men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases, according to final results from the ALSYMPCA trial.
Reuters Health Information
Original Article: Radium-223 Dichloride Safe Long-term for Prostate CA, Bone MetsNEXT ARTICLE
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...